METHODS OF TREATING DEMENTIA USING A GM-CSF ANTAGONIST

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130156759A1
SERIAL NO

13774367

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of a patient that has Alzheimer's disease or vascular dementia, or is at risk for developing Alzheimer's disease. Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody and pharmaceutical compositions comprising such antagonists.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KALOBIOS PHARMACEUTICALS INCSOUTH SAN FRANCISCO CA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bebbington, Christopher R South San Francisco, US 51 738
Palath, Varghese South San Francisco, US 12 86
Yarranton, Geoffrey T South San Francisco, US 45 626

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation